159 related articles for article (PubMed ID: 16439508)
21. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.
Bank I; Scavenius MP; Büller HR; Middeldorp S
Thromb Res; 2004; 113(1):7-12. PubMed ID: 15081560
[TBL] [Abstract][Full Text] [Related]
22. Clinical manifestations in thrombotic children with factor V Leiden mutation.
Gurgey A
Pediatr Hematol Oncol; 1999; 16(3):233-7. PubMed ID: 10326221
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
[TBL] [Abstract][Full Text] [Related]
24. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.
Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB
Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164
[TBL] [Abstract][Full Text] [Related]
25. Increased sperm count may account for high population frequency of factor V Leiden.
Cohn DM; Repping S; Büller HR; Meijers JC; Middeldorp S
J Thromb Haemost; 2010 Mar; 8(3):513-6. PubMed ID: 20002540
[TBL] [Abstract][Full Text] [Related]
26. Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan.
Obeidat NM; Awidi A; Sulaiman NA; Abu-Khader IB
Saudi Med J; 2009 Jul; 30(7):921-5. PubMed ID: 19618008
[TBL] [Abstract][Full Text] [Related]
27. Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss.
Glueck CJ; Gogenini S; Munjal J; Tracy T; Pranikoff J; Wang P
Fertil Steril; 2008 Feb; 89(2):410-6. PubMed ID: 17582408
[TBL] [Abstract][Full Text] [Related]
28. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs.
Dashti AA; Jadaon MM; Lewis HL
J Hum Genet; 2010 Apr; 55(4):232-5. PubMed ID: 20224595
[TBL] [Abstract][Full Text] [Related]
30. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
[TBL] [Abstract][Full Text] [Related]
31. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.
Eitzman DT; Westrick RJ; Shen Y; Bodary PF; Gu S; Manning SL; Dobies SL; Ginsburg D
Circulation; 2005 Apr; 111(14):1822-5. PubMed ID: 15809370
[TBL] [Abstract][Full Text] [Related]
32. Factor V Leiden mutation: a contributory factor for cerebral palsy?
Reid S; Halliday J; Ditchfield M; Ekert H; Byron K; Glynn A; Petrou V; Reddihough D
Dev Med Child Neurol; 2006 Jan; 48(1):14-9. PubMed ID: 16359589
[TBL] [Abstract][Full Text] [Related]
33. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A.
Lee DH; Walker IR; Teitel J; Poon MC; Ritchie B; Akabutu J; Sinclair GD; Pai M; Wu JW; Reddy S; Carter C; Growe G; Lillicrap D; Lam M; Blajchman MA
Thromb Haemost; 2000 Mar; 83(3):387-91. PubMed ID: 10744141
[TBL] [Abstract][Full Text] [Related]
34. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
35. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
[TBL] [Abstract][Full Text] [Related]
36. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss.
Ivanov PD; Komsa-Penkova RS; Konova EI; Kovacheva KS; Simeonova MN; Popov JD
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):134-40. PubMed ID: 19786941
[TBL] [Abstract][Full Text] [Related]
37. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients.
de Paula Sabino A; Ribeiro DD; Carvalho Md; Cardoso J; Dusse LM; Fernandes AP
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):271-5. PubMed ID: 16651869
[TBL] [Abstract][Full Text] [Related]
38. Factor V Leiden mutation and type 1 diabetes mellitus.
Demirer AN; Alikasifoglu M; Tuncbilek E; Karakus S; Erbas T
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
[TBL] [Abstract][Full Text] [Related]
39. [Risk of thrombophilia in carriers of thrombophilic genetic factors in unsuccessful assisted reproduction].
Ivanov P; Komsa-Penkova R; Kovacheva K; Konova E; Todorova K; Simeonova M; Ivanov I; Stoĭkov S; Popov I; Tanchev S; Bozhinova S
Akush Ginekol (Sofiia); 2007; 46(6):3-8. PubMed ID: 17974163
[TBL] [Abstract][Full Text] [Related]
40. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
